Clinical Trial Update: Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial update of tretinoin and arsenic trioxide for untreated acute promyelocytic leukemia; results have been posted and the trial is active-not-recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)
• TRETINOIN (TRETINOIN)

Snippet

Sponsor: Children's Oncology Group | Conditions: Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-12-16